Here’s What’s Concerning About Arabian International Healthcare Holding’s (TADAWUL:9530) Returns On Capital

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. Amongst other things, we’ll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company’s amount of capital employed. This shows us that it’s a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. Although, when we looked at Arabian International Healthcare Holding (TADAWUL:9530), it didn’t seem to tick all of these boxes.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

Understanding Return On Capital Employed (ROCE)

Just to clarify if you’re unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. Analysts use this formula to calculate it for Arabian International Healthcare Holding:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets – Current Liabilities)

0.079 = ر.س42m ÷ (ر.س1.4b – ر.س818m) (Based on the trailing twelve months to December 2024).

So, Arabian International Healthcare Holding has an ROCE of 7.9%. In absolute terms, that’s a low return and it also under-performs the Healthcare industry average of 13%.

Check out our latest analysis for Arabian International Healthcare Holding

Historical performance is a great place to start when researching a stock so above you can see the gauge for Arabian International Healthcare Holding’s ROCE against it’s prior returns. If you’re interested in investigating Arabian International Healthcare Holding’s past further, check out this free graph covering Arabian International Healthcare Holding’s past earnings, revenue and cash flow.

What Can We Tell From Arabian International Healthcare Holding’s ROCE Trend?

On the surface, the trend of ROCE at Arabian International Healthcare Holding doesn’t inspire confidence. To be more specific, ROCE has fallen from 19% over the last five years. However it looks like Arabian International Healthcare Holding might be reinvesting for long term growth because while capital employed has increased, the company’s sales haven’t changed much in the last 12 months. It’s worth keeping an eye on the company’s earnings from here on to see if these investments do end up contributing to the bottom line.

On a related note, Arabian International Healthcare Holding has decreased its current liabilities to 61% of total assets. So we could link some of this to the decrease in ROCE. Effectively this means their suppliers or short-term creditors are funding less of the business, which reduces some elements of risk. Since the business is basically funding more of its operations with it’s own money, you could argue this has made the business less efficient at generating ROCE. Either way, they’re still at a pretty high level, so we’d like to see them fall further if possible.

The Key Takeaway

In summary, Arabian International Healthcare Holding is reinvesting funds back into the business for growth but unfortunately it looks like sales haven’t increased much just yet. And investors appear hesitant that the trends will pick up because the stock has fallen 34% in the last three years. On the whole, we aren’t too inspired by the underlying trends and we think there may be better chances of finding a multi-bagger elsewhere.

Since virtually every company faces some risks, it’s worth knowing what they are, and we’ve spotted 4 warning signs for Arabian International Healthcare Holding (of which 2 are a bit unpleasant!) that you should know about.

While Arabian International Healthcare Holding may not currently earn the highest returns, we’ve compiled a list of companies that currently earn more than 25% return on equity. Check out this free list here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.